Bone marrow infection with bacillus Calmette-Guerin (BCG) after intravesical immunotherapy

被引:0
作者
Nemeth, Johannes [1 ]
Stoiser, Brigitte [1 ]
Winkler, Heide-Maria [1 ]
Muellauer, Leonard [2 ]
Graninger, Wolfgang [1 ]
Winkler, Stefan [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria
关键词
BCG; bladder cancer; bone marrow infection; pancytopenia;
D O I
10.1007/s00508-007-0902-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Instillation of bacillus Calmette-Guerin (BCG) into the urine bladder is an effective treatment of superficial bladder cancer. BCG-mediated anti-tumor activity appears to be a local phenomenon in which cell-mediated immunity, involving cytotoxic T cells, lymphokine-activated killer cells and natural killer cells, is important for the elimination of malignant cells. Serious side-effects of BCG therapy are rare; nevertheless, BCG is a live, attenuated strain of Mycobacterium (M.) bovis and may exhibit invasive properties. Both local and distant or generalized infections have been reported after treatment with BCG. We describe the case of a 68-year-old man who developed bone marrow infection with BCG two years after intravesical instillation of BCG for treatment of superficial bladder cancer. He presented with intermittent fever, weight loss and pronounced pancytopenia. A bone marrow biopsy specimen showed granulomatous inflammation and BCG was cultured from the urine. Anti-mycobacterial treatment with isoniazid, rifampicin and ethambutol (pyrazinamide is inactive against M. bovis) led to full clinical recovery of the patient.
引用
收藏
页码:121 / 123
页数:3
相关论文
共 14 条
[1]  
Dederke B, 1998, INFECTION, V26, P58
[2]   HYPERSENSITIVITY REACTION TO BACILLUS CALMETTE-GUERIN TREATED WITH PLASMAPHERESIS [J].
DEHERTOGH, D ;
FIERER, E ;
ORELL, JA .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (03) :343-344
[3]   Sepsis and multiple organ failure after BCG-instillation for bladder cancer [J].
Elmer, A ;
Bermes, U ;
Drath, L ;
Büscher, E ;
Viertel, A .
INTERNIST, 2004, 45 (08) :935-939
[4]   Spectrum of Bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy [J].
Gonzalez, OY ;
Musher, DM ;
Brar, I ;
Furgeson, S ;
Boktour, MR ;
Septimus, EJ ;
Hamill, RJ ;
Graviss, EA .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) :140-148
[5]   Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials [J].
Han, Rui Fa ;
Pan, Jian Gang .
UROLOGY, 2006, 67 (06) :1216-1223
[6]   PULMONARY-DISEASE FOLLOWING INTRAVESICAL BCG TREATMENT [J].
KESTEN, S ;
TITLE, L ;
MULLEN, B ;
GROSSMAN, R .
THORAX, 1990, 45 (09) :709-710
[7]   Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer [J].
Lamm, DL .
CLINICAL INFECTIOUS DISEASES, 2000, 31 :S86-S90
[8]  
Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149
[9]   Drug points -: Systemic granulomatous disease after intravesical BCG instillation [J].
Mooren, FC ;
Lerch, MM ;
Ullerich, H ;
Bürger, H ;
Domschke, W .
BRITISH MEDICAL JOURNAL, 2000, 320 (7229) :219-219
[10]   INTRACAVITARY BACILLUS CALMETTE-GUERIN IN TREATMENT OF SUPERFICIAL BLADDER TUMORS [J].
MORALES, A ;
EIDINGER, D ;
BRUCE, AW .
JOURNAL OF UROLOGY, 1976, 116 (02) :180-183